Seminoma Clinical Trial
Official title:
MicroRNA-371 as Markers for Disease Activity and as a Tool to Monitor the Effect of Chemotherapy and Early Detection of Recurrence in Patients With Testicular Germ Cell Tumours
The main objective of this study is establish the performance of miR371 in management of testicular cancer
The main objective of the study is to asses the sensitivity and specificity of microRNA-371a-5p (miR371) in detection of viable testicular germ tumour cells. To assess the utility of miR371 at orchiectomy, during treatment and surveillance and in early detection of recurrence. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06133543 -
Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer
|
N/A | |
| Recruiting |
NCT05529251 -
De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
|
Phase 2 | |
| Completed |
NCT00705094 -
Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
|
N/A | |
| Active, not recruiting |
NCT03158064 -
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
|
Phase 2 | |
| Recruiting |
NCT01887340 -
Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
|
Phase 2 | |
| Active, not recruiting |
NCT01593241 -
Therapy De-escalation in Seminoma Stage IIA/B
|
Phase 2 | |
| Recruiting |
NCT04876456 -
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
|
Phase 2 | |
| Active, not recruiting |
NCT03937843 -
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
|
Phase 2 | |
| Recruiting |
NCT04435756 -
A Study of miRNA 371 in Patients With Germ Cell Tumors
|
||
| Active, not recruiting |
NCT02834013 -
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
|
Phase 2 | |
| Recruiting |
NCT06309745 -
THERApy De-escalation for TESTicular Cancer
|
||
| Not yet recruiting |
NCT05142982 -
Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma
|
N/A | |
| Active, not recruiting |
NCT02375204 -
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
|
Phase 3 | |
| Recruiting |
NCT06144736 -
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
|
Phase 2 | |
| Recruiting |
NCT02341989 -
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
|
Phase 3 |